7Baggers
 published on: 2025-11-16 13:27:27  newser.com Sun, 16 Nov 2025 19:27:27 GMT
 published on: 2025-11-15 00:30:31  newser.com Sat, 15 Nov 2025 06:30:31 GMT
 Published on: 2025-11-14 05:59:36  newser.com Fri, 14 Nov 2025 11:59:36 GMT
 vyne therapeutics reports q3 2025 financial results  TipRanks Fri, 07 Nov 2025 05:30:35 GMT
 vyne therapeutics inc. (vyne) reports q3 loss, tops revenue estimates  sharewise.com Fri, 07 Nov 2025 04:37:03 GMT
 VYNE Achieves Revenue Growth and Advances Strategic Initiatives  GuruFocus Fri, 07 Nov 2025 04:34:27 GMT
 vyne therapeutics reports q3 eps (17c) vs (29c) last year  TipRanks Fri, 07 Nov 2025 03:41:26 GMT
 VYNE Therapeutics Cuts Losses And Eyes Strategic Moves  Finimize Thu, 06 Nov 2025 21:23:32 GMT
 vyne achieves revenue growth and advances strategic initiatives  GuruFocus Thu, 06 Nov 2025 13:54:37 GMT
 VYNE Therapeutics Q3 net loss narrows, strategic review ongoing  TradingView Thu, 06 Nov 2025 13:07:19 GMT
 VYNE Therapeutics Inc. (VYNE) Reports Q3 Loss, Tops Revenue Estimates  Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
 VYNE Therapeutics Reports Q3 2025 Financial Results  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 published on: 2025-11-05 02:23:24  newser.com Wed, 05 Nov 2025 08:23:24 GMT
 published on: 2025-11-03 06:13:50  newser.com Mon, 03 Nov 2025 12:13:50 GMT

VYNE Therapeutics Inc
(NASDAQ:VYNE) 

VYNE stock logo

VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapeutics for dermatology. The company offers AMZEEQ, a topical minocycline used for the treatment of inflammatory lesions of non-nodular moderate-to-severe acne vulgaris in patients 9 years of age...

Founded: 2003
CEO: David Domzalski  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends